MLANA and melanoma: To this end, both of these ERAD components were knocked down by siRNA in the Ma-Mel-91-melanoma cell line (Melan-A/MART-1−/HLA-A*0201+) which was subsequently engineered to express the Melan-A/MART-1 antigen.